• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤细胞来源的外泌体 miR-1307 通过靶向 AGAP1 促进肿瘤发生。

Osteosarcoma Cell-Derived Exosomal miR-1307 Promotes Tumorgenesis via Targeting AGAP1.

机构信息

Department of Orthopaedics, The First Affiliated Hospital of the Medical College, Shihezi University, Shihezi, China.

Medical College, Shihezi University, Shihezi, China.

出版信息

Biomed Res Int. 2021 Mar 25;2021:7358153. doi: 10.1155/2021/7358153. eCollection 2021.

DOI:10.1155/2021/7358153
PMID:33834074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8016573/
Abstract

The occurrence of osteosarcoma (OS) is associated with abnormal expression of many microRNAs (miRNAs). Exosomal miRNAs get much more attentions in intracellular communications. miR-1307 has been studied in many cancers, but its effects in OS have not been studied. We hypothesized that OS-derived exosomal miR-1307 regulates OS tumorigenesis. First, we found OS cell-derived exosomes (Exos) significantly promoted the proliferation, migration, and invasion of OS cells. Secondly, we found miR-1307 was highly expressed in OS cell-derived exosomes (OS-Exos), human OS tissues, and OS cell lines. Then, OS-Exos were extracted after OS cells were cultured and transfected with miR-1307 inhibitor, and the level of miR-1307 in OS-Exos was significantly reduced. When the level of miR-1307 in OS-Exos was significantly reduced, the effects of OS-Exos on migration, invasion, and proliferation of OS cells were also significantly weakened. Furthermore, using TargetScan, miRDB, and mirDIP databases, we identified that AGAP1 was a target gene of miR-1307. Overexpression of miR-1307 could inhibit the expression of AGAP1 gene. We also found AGAP1 was lower expressed in human OS tissues and OS cell lines. Luciferase gene indicated that miR-1307 directly bound the 3'-UTR of AGAP1. miR-1307 was negatively correlated with AGAP1 in clinical study. miR-1307 could significantly promote the proliferation, migration, and invasion of OS cells. In addition, upregulation of AGAP1 could significantly inhibit the role of miR-1307 in OS. In conclusion, our study suggests that OS cell-derived exosomal miR-1307 promotes the proliferation, migration, and invasion of OS cells via targeting AGAP1, and miR-1307-AGAP1 axis may play an important role in the future treatment of OS.

摘要

骨肉瘤(OS)的发生与许多 microRNAs(miRNAs)的异常表达有关。细胞内通讯中,外泌体 miRNAs 受到了更多关注。miR-1307 在许多癌症中都有研究,但在 OS 中的作用尚未研究。我们假设 OS 来源的外泌体 miR-1307 调节 OS 肿瘤发生。首先,我们发现 OS 细胞来源的外泌体(Exos)显著促进了 OS 细胞的增殖、迁移和侵袭。其次,我们发现 miR-1307 在 OS 细胞来源的外泌体(OS-Exos)、人 OS 组织和 OS 细胞系中高表达。然后,在 OS 细胞培养并转染 miR-1307 抑制剂后提取 OS-Exos,OS-Exos 中的 miR-1307 水平显著降低。当 OS-Exos 中的 miR-1307 水平显著降低时,OS-Exos 对 OS 细胞迁移、侵袭和增殖的作用也显著减弱。此外,通过使用 TargetScan、miRDB 和 mirDIP 数据库,我们鉴定出 AGAP1 是 miR-1307 的靶基因。miR-1307 的过表达可以抑制 AGAP1 基因的表达。我们还发现 AGAP1 在人 OS 组织和 OS 细胞系中表达较低。荧光素酶基因表明 miR-1307 可直接结合 AGAP1 的 3'-UTR。临床研究表明 miR-1307 与 AGAP1 呈负相关。miR-1307 可显著促进 OS 细胞的增殖、迁移和侵袭。此外,上调 AGAP1 可显著抑制 miR-1307 在 OS 中的作用。综上所述,本研究表明,OS 细胞来源的外泌体 miR-1307 通过靶向 AGAP1 促进 OS 细胞的增殖、迁移和侵袭,miR-1307-AGAP1 轴可能在未来 OS 的治疗中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/32b7a771ccc7/BMRI2021-7358153.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/cb0fad553dce/BMRI2021-7358153.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/9649f2b2bf3f/BMRI2021-7358153.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/30a1eb30b8ef/BMRI2021-7358153.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/5c9cb23a0b0d/BMRI2021-7358153.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/a3dc74ad0f7a/BMRI2021-7358153.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/2e9a85939e15/BMRI2021-7358153.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/040ce2ccf037/BMRI2021-7358153.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/ddaaf5c81ea3/BMRI2021-7358153.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/b166666a0618/BMRI2021-7358153.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/32b7a771ccc7/BMRI2021-7358153.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/cb0fad553dce/BMRI2021-7358153.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/9649f2b2bf3f/BMRI2021-7358153.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/30a1eb30b8ef/BMRI2021-7358153.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/5c9cb23a0b0d/BMRI2021-7358153.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/a3dc74ad0f7a/BMRI2021-7358153.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/2e9a85939e15/BMRI2021-7358153.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/040ce2ccf037/BMRI2021-7358153.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/ddaaf5c81ea3/BMRI2021-7358153.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/b166666a0618/BMRI2021-7358153.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bc/8016573/32b7a771ccc7/BMRI2021-7358153.010.jpg

相似文献

1
Osteosarcoma Cell-Derived Exosomal miR-1307 Promotes Tumorgenesis via Targeting AGAP1.骨肉瘤细胞来源的外泌体 miR-1307 通过靶向 AGAP1 促进肿瘤发生。
Biomed Res Int. 2021 Mar 25;2021:7358153. doi: 10.1155/2021/7358153. eCollection 2021.
2
Exosomal miR-675 from metastatic osteosarcoma promotes cell migration and invasion by targeting CALN1.转移性骨肉瘤来源的外泌体 miR-675 通过靶向 CALN1 促进细胞迁移和侵袭。
Biochem Biophys Res Commun. 2018 Jun 2;500(2):170-176. doi: 10.1016/j.bbrc.2018.04.016. Epub 2018 Apr 11.
3
MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.miR-363 通过与 NOB1 结合抑制骨肉瘤细胞迁移、侵袭和上皮-间充质转化。
World J Surg Oncol. 2020 May 1;18(1):83. doi: 10.1186/s12957-020-01859-y.
4
LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis.长链非编码 RNA SNHG16 通过靶向 miR-1301/BCL9 轴促进骨肉瘤细胞的增殖、迁移和侵袭。
Biomed Pharmacother. 2019 Jun;114:108798. doi: 10.1016/j.biopha.2019.108798. Epub 2019 Mar 22.
5
miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.miR-216a 通过靶向 CDK14 抑制骨肉瘤细胞的增殖、侵袭和转移。
Cell Death Dis. 2017 Oct 12;8(10):e3103. doi: 10.1038/cddis.2017.499.
6
Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1.长链非编码 RNA SNHG5 通过靶向 ROCK1 海绵 miR-26a 促进骨肉瘤的发生。
Biomed Pharmacother. 2018 Nov;107:598-605. doi: 10.1016/j.biopha.2018.08.025. Epub 2018 Aug 14.
7
Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.miR-664的过表达通过靶向SOX7与骨肉瘤细胞迁移和侵袭能力增强相关。
Clin Exp Med. 2017 Feb;17(1):51-58. doi: 10.1007/s10238-015-0398-6. Epub 2015 Oct 29.
8
miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.微小RNA-1通过靶向骨肉瘤细胞中的血管内皮生长因子A抑制细胞生长、迁移和侵袭。
Dis Markers. 2016;2016:7068986. doi: 10.1155/2016/7068986. Epub 2016 Sep 29.
9
MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.MALAT1通过miR-142-3p和miR-129-5p调控HMGB1来促进骨肉瘤发展。
Cell Cycle. 2017 Mar 19;16(6):578-587. doi: 10.1080/15384101.2017.1288324. Epub 2017 Feb 10.
10
MicroRNA-185 inhibits proliferation, migration and invasion in human osteosarcoma MG63 cells by targeting vesicle-associated membrane protein 2.微小 RNA-185 通过靶向囊泡相关膜蛋白 2 抑制人骨肉瘤 MG63 细胞的增殖、迁移和侵袭。
Gene. 2019 May 15;696:80-87. doi: 10.1016/j.gene.2019.01.034. Epub 2019 Feb 2.

引用本文的文献

1
The therapeutic potential of exosomes in bone cancers: osteosarcoma, chondrosarcoma, and Ewing sarcoma.外泌体在骨癌(骨肉瘤、软骨肉瘤和尤文肉瘤)中的治疗潜力。
Invest New Drugs. 2025 Jul 5. doi: 10.1007/s10637-025-01551-6.
2
Exploration of research hotspots and evolutionary trends in osteosarcoma pulmonary metastasis: A comprehensive bibliometric analysis spanning five decades.骨肉瘤肺转移的研究热点与进化趋势探索:一项跨越五十年的综合文献计量分析
J Orthop. 2025 Apr 5;63:181-195. doi: 10.1016/j.jor.2025.03.053. eCollection 2025 May.
3
Role of non-coding RNA in exosomes for the diagnosis and treatment of osteosarcoma.

本文引用的文献

1
AGAP1 regulates subcellular localization of FilGAP and control cancer cell invasion.AGAP1 调控 FilGAP 的亚细胞定位并控制癌细胞侵袭。
Biochem Biophys Res Commun. 2020 Feb 12;522(3):676-683. doi: 10.1016/j.bbrc.2019.11.147. Epub 2019 Nov 28.
2
Exosomal miR-17-5p promotes angiogenesis in nasopharyngeal carcinoma via targeting BAMBI.外泌体miR-17-5p通过靶向BAMBI促进鼻咽癌血管生成。
J Cancer. 2019 Oct 22;10(26):6681-6692. doi: 10.7150/jca.30757. eCollection 2019.
3
Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis.
非编码RNA在外泌体中在骨肉瘤诊断和治疗中的作用。
Front Oncol. 2024 Oct 24;14:1469833. doi: 10.3389/fonc.2024.1469833. eCollection 2024.
4
The molecular conversations of sarcomas: exosomal non-coding RNAs in tumor's biology and their translational prospects.肉瘤的分子对话:外泌体非编码 RNA 在肿瘤生物学中的作用及其转化前景。
Mol Cancer. 2024 Aug 22;23(1):172. doi: 10.1186/s12943-024-02083-y.
5
Exploring the Impact of Exosomal Cargos on Osteosarcoma Progression: Insights into Therapeutic Potential.探讨外泌体 cargo 对骨肉瘤进展的影响:治疗潜力的深入了解。
Int J Mol Sci. 2024 Jan 1;25(1):568. doi: 10.3390/ijms25010568.
6
Tumor microenvironment deconvolution identifies cell-type-independent aberrant DNA methylation and gene expression in prostate cancer.肿瘤微环境解卷积鉴定前列腺癌中细胞类型非依赖性异常 DNA 甲基化和基因表达。
Clin Epigenetics. 2024 Jan 3;16(1):5. doi: 10.1186/s13148-023-01609-3.
7
Identification of a glycolysis-related miRNA Signature for Predicting Breast cancer Survival.鉴定与糖酵解相关的 miRNA 特征,用于预测乳腺癌患者的生存情况。
Mol Biotechnol. 2024 Aug;66(8):1988-2006. doi: 10.1007/s12033-023-00837-5. Epub 2023 Aug 3.
8
Extracellular vesicles in tumorigenesis, metastasis, chemotherapy resistance and intercellular communication in osteosarcoma.细胞外囊泡在骨肉瘤发生、转移、化疗耐药和细胞间通讯中的作用。
Bioengineered. 2023 Dec;14(1):113-128. doi: 10.1080/21655979.2022.2161711.
9
Cellular and Genetic Background of Osteosarcoma.骨肉瘤的细胞与遗传背景
Curr Issues Mol Biol. 2023 May 15;45(5):4344-4358. doi: 10.3390/cimb45050276.
10
Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application.基于外泌体的骨与软组织肉瘤液体活检方法:文献综述、前景展望与临床应用的希望
Int J Mol Sci. 2023 Mar 8;24(6):5159. doi: 10.3390/ijms24065159.
卵巢癌细胞分泌的外泌体 miR-205 通过诱导血管生成促进转移。
Theranostics. 2019 Oct 18;9(26):8206-8220. doi: 10.7150/thno.37455. eCollection 2019.
4
Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2.胰腺癌细胞衍生的外泌体 microRNA-27a 通过 BTG2 促进胰腺癌中人类微血管内皮细胞的血管生成。
J Cell Mol Med. 2020 Jan;24(1):588-604. doi: 10.1111/jcmm.14766. Epub 2019 Nov 13.
5
miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.miR-1307-3p 通过抑制 DAB2 相互作用蛋白促进肝癌的肿瘤生长和转移。
Biomed Pharmacother. 2019 Sep;117:109055. doi: 10.1016/j.biopha.2019.109055. Epub 2019 Jun 5.
6
miR-1307-3p Stimulates Breast Cancer Development and Progression by Targeting SMYD4.miR-1307-3p 通过靶向SMYD4促进乳腺癌的发展和进展。
J Cancer. 2019 Jan 1;10(2):441-448. doi: 10.7150/jca.30041. eCollection 2019.
7
Exosomal miR-1228 From Cancer-Associated Fibroblasts Promotes Cell Migration and Invasion of Osteosarcoma by Directly Targeting SCAI.肿瘤相关成纤维细胞来源的外泌体 miR-1228 通过直接靶向 SCAI 促进骨肉瘤细胞迁移和侵袭。
Oncol Res. 2019 Sep 23;27(9):979-986. doi: 10.3727/096504018X15336368805108. Epub 2018 Aug 8.
8
Exosomal miR-675 from metastatic osteosarcoma promotes cell migration and invasion by targeting CALN1.转移性骨肉瘤来源的外泌体 miR-675 通过靶向 CALN1 促进细胞迁移和侵袭。
Biochem Biophys Res Commun. 2018 Jun 2;500(2):170-176. doi: 10.1016/j.bbrc.2018.04.016. Epub 2018 Apr 11.
9
miR-1307 promotes the proliferation of prostate cancer by targeting FOXO3A.miR-1307 通过靶向 FOXO3A 促进前列腺癌的增殖。
Biomed Pharmacother. 2017 Apr;88:430-435. doi: 10.1016/j.biopha.2016.11.120. Epub 2017 Jan 22.
10
MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.微小RNA-1307通过靶向ING5表达促进卵巢癌细胞的化疗耐药性。
J Ovarian Res. 2017 Jan 11;10(1):1. doi: 10.1186/s13048-016-0301-4.